Trade Summary

3 days ago, Girao Tiago, serving as Chief Financial Officer at Immunovant, Inc. (IMVT), sold 6,798 shares at $38.69 per share, for a total transaction value of $263,014.62. Following this transaction, Girao Tiago now holds 240,798 shares of IMVT.

This sale represents a 2.75% decrease in Girao Tiago's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 23, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 24, 2026 at 5:57 PM ET, 1 day after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.